当前位置:首页 > 文献互助 > 互助详情

Dose-intensified PSMA Radioligand Therapy: The Rationale Behind the OPTIMAL-PSMA Trial复制

用户1jAogkvl5Pfs 1个月前 114 10 已完结

1. 系统已在2026-10-15 12:04:49对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

G Sheehan-Dare, S Khan, L Emmett
European Urology Focus, 2026
Elsevier
A key unanswered question in prostate-specific membrane-antigen (PSMA) targeted radioligand therapy is whether we have chosen therapy doses and regimens that are “safe” rather than “effective,” with phase 3 trials to date guided by conservative external beam derived dose constraints. However, is increasing administered dose or short interval fractionated dose safe, and does it even make a difference to patient outcomes? The goal of the OPTIMAL-PSMA trial is to determine the depth of response and safety of intense …

互助时间线

2026-10-12 20:15:16 [完结求助]

系统完结了求助, 已自动确认了jodie0105应助的文件是正确的, 求助状态变成 已完结

2026-10-08 12:04:49 [上传文件]

jodie0105上传了文件(pdf 877.29 KB), 求助状态变成 待确认

2026-10-07 20:15:16 [发起求助]